Susquehanna International Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $229K | Buy |
64,000
+51,600
| +416% | +$205K | ﹤0.01% | 11443 |
|
|
2025
Q4 | $43.5K | Sell |
12,400
-267,500
| -96% | -$916K | ﹤0.01% | 11799 |
|
|
2025
Q3 | $912K | Sell |
279,900
-18,800
| -6% | -$59.2K | ﹤0.01% | 7565 |
|
|
2025
Q2 | $732K | Buy |
298,700
+261,900
| +712% | +$1.33M | ﹤0.01% | 8250 |
|
|
2025
Q1 | $245K | Buy |
36,800
+25,100
| +215% | +$248K | ﹤0.01% | 10506 |
|
|
2024
Q4 | $147K | Buy |
11,700
+200
| +2% | +$3.01K | ﹤0.01% | 11036 |
|
|
2024
Q3 | $212K | Hold |
11,500
| – | – | ﹤0.01% | 10349 |
|
|
2024
Q2 | $248K | Buy |
+11,500
| New | +$264K | ﹤0.01% | 9876 |
|
|
2024
Q1 | – | Sell |
-15,500
| Closed | -$465K | – | 13140 |
|
|
2023
Q4 | $465K | Sell |
15,500
-11,900
| -43% | -$263K | ﹤0.01% | 8852 |
|
|
2023
Q3 | $561K | Sell |
27,400
-16,000
| -37% | -$291K | ﹤0.01% | 7963 |
|
|
2023
Q2 | $862K | Buy |
43,400
+23,300
| +116% | +$471K | ﹤0.01% | 7030 |
|
|
2023
Q1 | $344K | Buy |
20,100
+6,100
| +44% | +$119K | ﹤0.01% | 9430 |
|
|
2022
Q4 | $274K | Buy |
14,000
+3,900
| +39% | +$71.8K | ﹤0.01% | 9309 |
|
|
2022
Q3 | $161K | Buy |
+10,100
| New | +$158K | ﹤0.01% | 11140 |
|
|
2022
Q2 | – | Sell |
-14,700
| Closed | -$233K | – | 13752 |
|
|
2022
Q1 | $233K | Buy |
+14,700
| New | +$254K | ﹤0.01% | 10873 |
|
|
2021
Q3 | – | Sell |
-36,300
| Closed | -$1.61M | – | 13411 |
|
|
2021
Q2 | $1.61M | Sell |
36,300
-39,300
| -52% | -$1.71M | ﹤0.01% | 6454 |
|
|
2021
Q1 | $3.35M | Sell |
75,600
-20,300
| -21% | -$1.11M | ﹤0.01% | 4722 |
|
|
2020
Q4 | $5.26M | Buy |
+95,900
| New | +$3.5M | ﹤0.01% | 3339 |
|
|
2020
Q1 | – | Sell |
-23,200
| Closed | -$528K | – | 10763 |
|
|
2019
Q4 | $528K | Sell |
23,200
-5,400
| -19% | -$90.2K | ﹤0.01% | 6886 |
|
|
2019
Q3 | $333K | Sell |
28,600
-114,500
| -80% | -$1.42M | ﹤0.01% | 8078 |
|
|
2019
Q2 | $2.15M | Buy |
143,100
+15,600
| +12% | +$272K | ﹤0.01% | 4040 |
|
|
2019
Q1 | $2.24M | Buy |
+127,500
| New | +$2.01M | ﹤0.01% | 3585 |
|
|
2018
Q2 | – | Sell |
-11,900
| Closed | -$223K | – | 10252 |
|
|
2018
Q1 | $223K | Buy |
+11,900
| New | +$194K | ﹤0.01% | 8149 |
|
|
2017
Q3 | – | Sell |
-6,700
| Closed | -$51K | – | 9482 |
|
|
2017
Q2 | $51K | Buy |
6,700
+3,725
| +125% | +$27.8K | ﹤0.01% | 8883 |
|
|
2017
Q1 | $24K | Sell |
2,975
-34,125
| -92% | -$229K | ﹤0.01% | 8705 |
|
|
2016
Q4 | $905K | Buy |
37,100
+33,675
| +983% | +$961K | ﹤0.01% | 5742 |
|
|
2016
Q3 | $130K | Buy |
+3,425
| New | +$108K | ﹤0.01% | 7837 |
|
Other funds holding RCKT
RI
VPM
VCM
MC
NM
N
Susquehanna International Group's RCKT Position: Q1 2026 in Review
Susquehanna International Group increased its Rocket Pharmaceuticals (RCKT) stake by 99% in Q1 2026, buying an estimated $764K and bringing the position to 385,639 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #7094.
Susquehanna International Group first reported a position in RCKT in Q4 2015 and has held it in 31 quarters since. The position peaked at $7.1M in Q1 2021. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.
- Susquehanna International Group held 385,639 shares of Rocket Pharmaceuticals worth $1.38M as of Q1 2026.
- Susquehanna International Group bought 192,209 Rocket Pharmaceuticals shares in Q1 2026, an estimated $764K.
- Rocket Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7094 holding.
- Susquehanna International Group first reported a position in Rocket Pharmaceuticals in Q4 2015 and has held it in 31 quarters since.
- Susquehanna International Group's Rocket Pharmaceuticals position peaked at $7.1M in Q1 2021.
- 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.